The Full Wiki

David Nutt: Quiz


Did you know ...

More interesting facts on David Nutt

Include this on your site/blog:
Question 1: This involves the study of ________, using labelled subtypes of GABA 5, and serotonin, or 5-HT, receptors.
5-HT receptorGlutamate receptorGABA receptorPurinergic receptor

Question 2: He is a Fellow of the ________, Royal College of Psychiatrists and the Academy of Medical Sciences.
Amen Corner (London)Christopher MerretLumleian LecturesRoyal College of Physicians

Question 3: Following the release of this pamphlet, Nutt was dismissed from his ACMD position by the Home Secretary, ________.
David BlunkettKenneth ClarkeAlan JohnsonJack Straw

Question 4: From 1983 to 1985, he lectured in psychiatry at the ________.
Oxford Brookes UniversityUniversity of CambridgeUniversity of OxfordUniversity of Southampton

Question 5: [7] In January 2008 he was appointed as the chairman of the ________ (ACMD), having previously been Chair of the Technical Committee of the ACMD for seven years.
Advisory Council on the Misuse of DrugsJacqui SmithDavid NuttAlan Johnson

Question 6: Type 1 5-HT receptors seem to be especially important in depression and the action of ________.

Question 7: Professor Nutt studied medicine at the ________, graduating in 1972 and completing his clinical training at Guy's Hospital in 1975.
University of CambridgeUniversity of EdinburghUniversity of OxfordUniversity of Bristol

Question 8: Explaining his sacking of Nutt, ________ wrote in a letter to The Guardian, that "He was asked to go because he cannot be both a government adviser and a campaigner against government policy.
David BlunkettAlan JohnsonKenneth ClarkeJack Straw

Question 9: [1 ] He is a professor at the ________ heading their Psychopharmacology Unit.
University of OxfordUniversity of CambridgeUniversity of EdinburghUniversity of Bristol

Question 10: His participation was criticised as, owing to his financial interest in ________, he had to withdraw from discussions of the drug Seroxat.
Shire plcGlaxoSmithKlineVodafoneAstraZeneca

Got something to say? Make a comment.
Your name
Your email address